0.1% TR 987: Clinical Trials

1 trial of 0.1% TR 987, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow 0.1% TR 987: new trials by email Literature Review of 0.1% TR 987 trials Research Report on 0.1% TR 987

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
0.1% TR 987, Placebo gel - Venous Leg Ulcer
Phase 2Active not recruitingSerenaGroup, Inc.802016-11-012020-10-22

Conditions studied

Varicose Ulcer (1)

Sponsors

SerenaGroup, Inc. (1)

Countries

United States (1)

Top investigators

Thomas Serena, MD (1)